A multi-country & multi-center study to assess the efficacy, immunogenicity & safety of two doses of GSK Biologicals' oral live attenuated HRV vaccine given concomitantly with routine EPI vaccinations including OPV in healthy infants
Rotavirus Vaccine
Infections, Rotavirus
Phase 3
A link to and a NCT ID number is not available for this study because the study was conducted before regulatory requirements to register studies.
January 2014